Clinical Utility of Pharmacogenomics of Psychotropic Medications

NCT03907124 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI left institution prior to recruitment.

Conditions

Psychiatric Disorders
Pain

Interventions

DRUG: Genetically-guided treatment with FDA-approved psychotropic drugs
DRUG: Treatment as usual (TAU)

Sponsor

Oregon Health and Science University